TERT-BUTYL 2-OXO-5-AZASPIRO[3.5]NONANE-5-CARBOXYLATE, 95.0%, 5g

valerenic acid, with analyt. Documents, 200 mg, glass packaging

2-Methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethyl]phenol, 97%, 50mg

N-(4-Bromo-3-fluorobenzyl)morpholine, 97%, 500mg

2-Chloro-6-(trifluoromethyl)pyridin-4-amine, 95.0%, 1g

(E)-4-(2,4-Dichloro-phenyl)-but-3-en-2-one, 95.0%, 10g

(S)-2-amino-3-(2,3,6-trifluorophenyl)propanoic acid, 97%, 100mg

Fmoc-4-hydrazinobenzoic acid, 96.0%, 5g

1-Fluoro-4-(phenylsulfanylmethyl)benzene, 97.0%, 5g

2-Amino-5-bromopyrimidine, 98.0%, 500g

tert-Butyl 7-hydroxy-2-azabicyclo[2.2.1]heptane-2-carboxylate, 97%, 1g

1-(Sec-butyl)-2-nitrobenzene, 95+%, 1g

(4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid, 1g